The role the midwives play in women's healthcare in Chile demonstrates appropriate utilization of human resources according to their capacity to provide services. Historically, the Chilean midwife came into being more than 160 years ago, exclusively as a birth attendant. The midwives' functions have evolved, particularly during the last few decades, following the demographic and epidemiological evolution of the Chilean population and the new paradigm of healthcare addressed to woman throughout her life cycle, not only during pregnancy and childbirth. At the present time, the midwife is the professional that provides the great majority of gynecological and obstetrics care at the primary healthcare level, while also attending most of the deliveries in the public health services. The close link with physicians working as a team, and the emotional ties of the midwife as a provider with the woman as a client, is emphasized as an additional advantage of the presence of the midwife as a key person in women's healthcare.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0020-7292(98)00185-4 | DOI Listing |
Nutrients
December 2024
Department of Food & Nutrition & Research Institute of Obesity Sciences, Sungshin Women's University, Dobongro-76gagil-55, Kangbuk-ku, Seoul 01133, Republic of Korea.
Unlabelled: This study investigated how the gene variation related to RMR alteration affects risk factors of obese environments in children with obesity aged 8-9.
Methods: Over a three-year follow-up period, 63.3% of original students participated.
Nutrients
December 2024
School of Healthcare, University of Leeds, Leeds LS2 9JT, UK.
Objective: To investigate primiparous women's partners for knowledge, attitudes, and practices regarding the physical home food environment (PHFE), and to assess if the first pregnancy provides a teachable opportunity to enhance the PHFE of first-time pregnant couples.
Design: This was a two-phase longitudinal in-depth qualitative study involving questionnaires and individual interviews during and after pregnancy.
Participants: Fifteen male partners of primigravida women.
Pharmaceuticals (Basel)
December 2024
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Background: Leiomyoma (LM) is the most commonly identified tumor in the genital tract, occurring in 70-80% of women. The only treatment option is surgery, which significantly influences healthcare costs and negatively influences women's survival and reproductive capacity. Therefore, identifying safe and effective chemopreventive and treatment modalities is needed.
View Article and Find Full Text PDFMedicina (Kaunas)
December 2024
Department of Translational Medicine, University of Piemonte Orientale, Gynecology and Obstetrics, 'Maggiore della Carità' Hospital, 28100 Novara, Italy.
: Conscientious objection to voluntary abortion remains a hot debate topic. This could affect the accessibility to pregnancy termination. Our aim is to evaluate the possible aspects related to an operators' choice about objection for voluntary abortion, such as the following: the abolition of the time limit, the instruction of a multi-collegiate commission, the introduction of pharmacological rather than surgical procedures, the fetal/maternal illness and the case of sexual violence.
View Article and Find Full Text PDFJ Clin Med
December 2024
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
: The rapid onset of COVID-19 placed immense strain on many already overstretched healthcare systems. The unique physiological changes in pregnancy, amplified by the complex effects of COVID-19 in pregnant women, rendered prioritization of infected expectant mothers more challenging. This work aims to use state-of-the-art machine learning techniques to predict whether a COVID-19-infected pregnant woman will be admitted to ICU (Intensive Care Unit).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!